This study shows that angiogenin expression is up - regulated in the cytoplasmic and nuclear compartments in in situ carcinoma and invasive carcinoma compared with normal breast tissue and that angiogenin expression in invasive carcinomas is significantly positively associated with high tumour grade ( p = 0. 03), positive oestrogen receptor ( ER) status ( p = 0. 01), HIF - 1 alpha ( p = 0. 001) and DEC 1 ( p = 0. 001), but not with patient age ( p = 0. 8), tumour size ( p = 0. 25), lymph node status ( p = 0. 69), epidermal growth factor receptor ( p = 0. 56) or microvessel density ( p = 0. 32).	"angiogenin	22	32	Gene_or_gene_product"	"cytoplasmic	69	80	Organism_substance"	"nuclear	85	92	Cellular_component"	"carcinoma	117	126	Cancer"	"carcinoma	140	149	Cancer"	"breast tissue	171	184	Tissue"	"angiogenin	194	204	Gene_or_gene_product"	"carcinomas	228	238	Cancer"	"tumour	288	294	Cancer"	"oestrogen receptor	324	342	Gene_or_gene_product"	"ER	345	347	Gene_or_gene_product"	"HIF - 1 alpha	370	383	Gene_or_gene_product"	"DEC 1	402	407	Gene_or_gene_product"	"patient	436	443	Organism"	"tumour	461	467	Cancer"	"lymph node	487	497	Multi"	"epidermal growth factor receptor	519	551	Gene_or_gene_product"	"microvessel	568	579	Tissue"	"[{""token"": ""angiogenin"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasmic"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Organism_substance""}, {""token"": ""nuclear"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Cellular_component""}, {""token"": ""carcinoma"", ""start_span"": 117, ""end_span"": 126, ""type"": ""Cancer""}, {""token"": ""carcinoma"", ""start_span"": 140, ""end_span"": 149, ""type"": ""Cancer""}, {""token"": ""breast tissue"", ""start_span"": 171, ""end_span"": 184, ""type"": ""Tissue""}, {""token"": ""angiogenin"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinomas"", ""start_span"": 228, ""end_span"": 238, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 288, ""end_span"": 294, ""type"": ""Cancer""}, {""token"": ""oestrogen receptor"", ""start_span"": 324, ""end_span"": 342, ""type"": ""Gene_or_gene_product""}, {""token"": ""ER"", ""start_span"": 345, ""end_span"": 347, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1 alpha"", ""start_span"": 370, ""end_span"": 383, ""type"": ""Gene_or_gene_product""}, {""token"": ""DEC 1"", ""start_span"": 402, ""end_span"": 407, ""type"": ""Gene_or_gene_product""}, {""token"": ""patient"", ""start_span"": 436, ""end_span"": 443, ""type"": ""Organism""}, {""token"": ""tumour"", ""start_span"": 461, ""end_span"": 467, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 487, ""end_span"": 497, ""type"": ""Multi""}, {""token"": ""epidermal growth factor receptor"", ""start_span"": 519, ""end_span"": 551, ""type"": ""Gene_or_gene_product""}, {""token"": ""microvessel"", ""start_span"": 568, ""end_span"": 579, ""type"": ""Tissue""}]"
